Editorial: TRLs (triglycerides-rich lipoproteins): a new target for atherosclerosis

Saved in:
Bibliographic Details
Main Authors: Mei Dong, Yunlong Yang, Kayoko Hosaka, Yun Zhang, Yuxia Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2024.1540602/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841543847208812544
author Mei Dong
Yunlong Yang
Kayoko Hosaka
Yun Zhang
Yuxia Zhao
Yuxia Zhao
author_facet Mei Dong
Yunlong Yang
Kayoko Hosaka
Yun Zhang
Yuxia Zhao
Yuxia Zhao
author_sort Mei Dong
collection DOAJ
format Article
id doaj-art-89df75b0e19b48caa4624e712757693d
institution Kabale University
issn 1664-2392
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj-art-89df75b0e19b48caa4624e712757693d2025-01-13T05:10:17ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922025-01-011510.3389/fendo.2024.15406021540602Editorial: TRLs (triglycerides-rich lipoproteins): a new target for atherosclerosisMei Dong0Yunlong Yang1Kayoko Hosaka2Yun Zhang3Yuxia Zhao4Yuxia Zhao5State Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Department of Cardiology, Qilu Hospital of Shandong University, Jinan, ChinaDepartment of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, ChinaDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, SwedenState Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Department of Cardiology, Qilu Hospital of Shandong University, Jinan, ChinaState Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Department of Cardiology, Qilu Hospital of Shandong University, Jinan, ChinaDepartment of Traditional Chinese Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, Chinahttps://www.frontiersin.org/articles/10.3389/fendo.2024.1540602/fulltriglyceridelipoproteinatherosclerosisapo CIIIlipoprotein lipase (LPL)
spellingShingle Mei Dong
Yunlong Yang
Kayoko Hosaka
Yun Zhang
Yuxia Zhao
Yuxia Zhao
Editorial: TRLs (triglycerides-rich lipoproteins): a new target for atherosclerosis
Frontiers in Endocrinology
triglyceride
lipoprotein
atherosclerosis
apo CIII
lipoprotein lipase (LPL)
title Editorial: TRLs (triglycerides-rich lipoproteins): a new target for atherosclerosis
title_full Editorial: TRLs (triglycerides-rich lipoproteins): a new target for atherosclerosis
title_fullStr Editorial: TRLs (triglycerides-rich lipoproteins): a new target for atherosclerosis
title_full_unstemmed Editorial: TRLs (triglycerides-rich lipoproteins): a new target for atherosclerosis
title_short Editorial: TRLs (triglycerides-rich lipoproteins): a new target for atherosclerosis
title_sort editorial trls triglycerides rich lipoproteins a new target for atherosclerosis
topic triglyceride
lipoprotein
atherosclerosis
apo CIII
lipoprotein lipase (LPL)
url https://www.frontiersin.org/articles/10.3389/fendo.2024.1540602/full
work_keys_str_mv AT meidong editorialtrlstriglyceridesrichlipoproteinsanewtargetforatherosclerosis
AT yunlongyang editorialtrlstriglyceridesrichlipoproteinsanewtargetforatherosclerosis
AT kayokohosaka editorialtrlstriglyceridesrichlipoproteinsanewtargetforatherosclerosis
AT yunzhang editorialtrlstriglyceridesrichlipoproteinsanewtargetforatherosclerosis
AT yuxiazhao editorialtrlstriglyceridesrichlipoproteinsanewtargetforatherosclerosis
AT yuxiazhao editorialtrlstriglyceridesrichlipoproteinsanewtargetforatherosclerosis